Chip Stewart
Overview
Explore the profile of Chip Stewart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
16760
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DLBclass: A Probabilistic Molecular Classifier to Guide Clinical Investigation and Practice in DLBCL
Chapuy B, Wood T, Stewart C, Dunford A, Wienand K, Khan S, et al.
Blood
. 2024 Dec;
PMID: 39680847
Diffuse large B-cell lymphoma (DLBCL) is a clinically and molecularly heterogeneous disease. The increasing recognition and targeting of genetically defined DLBCLs highlights the need for robust classification algorithms. We previously...
2.
Cieri N, Hookeri N, Stromhaug K, Li L, Keating J, Diaz-Fernandez P, et al.
Nat Biotechnol
. 2024 Aug;
PMID: 39169264
T cell alloreactivity against minor histocompatibility antigens (mHAgs)-polymorphic peptides resulting from donor-recipient (D-R) disparity at sites of genetic polymorphisms-is at the core of the therapeutic effect of allogeneic hematopoietic cell...
3.
Morton L, Lee O, Karyadi D, Bogdanova T, Stewart C, Hartley S, et al.
Nat Commun
. 2024 Jun;
15(1):5053.
PMID: 38871684
Childhood radioactive iodine exposure from the Chornobyl accident increased papillary thyroid carcinoma (PTC) risk. While cervical lymph node metastases (cLNM) are well-recognized in pediatric PTC, the PTC metastatic process and...
4.
Flechon L, Arib I, Dutta A, Hasan Bou Issa L, Sklavenitis-Pistofidis R, Tilmont R, et al.
Blood Adv
. 2024 Mar;
8(12):3109-3119.
PMID: 38513135
Mycosis fungoides (MF) is the most prevalent primary cutaneous T-cell lymphoma, with an indolent or aggressive course and poor survival. The pathogenesis of MF remains unclear, and prognostic factors in...
5.
Mouhieddine T, Nzerem C, Redd R, Dunford A, Leventhal M, Sklavenitis-Pistofidis R, et al.
Cancer Res Commun
. 2023 Nov;
3(12):2560-2571.
PMID: 38019104
Significance: Using our algorithm to differentiate tumor and germline mutations from CH mutations, we detected CH in approximately 10% of patients with newly diagnosed myeloma, including both transplant eligible and...
6.
Bao C, Tourdot R, Brunette G, Stewart C, Sun L, Baba H, et al.
Nat Commun
. 2023 Oct;
14(1):6203.
PMID: 37794034
The progression of precancerous lesions to malignancy is often accompanied by increasing complexity of chromosomal alterations but how these alterations arise is poorly understood. Here we perform haplotype-specific analysis of...
7.
Ravi A, Hellmann M, Arniella M, Holton M, Freeman S, Naranbhai V, et al.
Nat Genet
. 2023 Apr;
55(5):807-819.
PMID: 37024582
Anti-PD-1/PD-L1 agents have transformed the treatment landscape of advanced non-small cell lung cancer (NSCLC). To expand our understanding of the molecular features underlying response to checkpoint inhibitors in NSCLC, we...
8.
Rheinbay E, Nielsen M, Abascal F, Wala J, Shapira O, Tiao G, et al.
Nature
. 2023 Jan;
614(7948):E40.
PMID: 36697832
No abstract available.
9.
Parry E, Leshchiner I, Guieze R, Johnson C, Tausch E, Parikh S, et al.
Nat Med
. 2023 Jan;
29(1):158-169.
PMID: 36624313
Richter syndrome (RS) arising from chronic lymphocytic leukemia (CLL) exemplifies an aggressive malignancy that develops from an indolent neoplasm. To decipher the genetics underlying this transformation, we computationally deconvoluted admixtures...
10.
Dutta A, Alberge J, Lightbody E, Boehner C, Dunford A, Sklavenitis-Pistofidis R, et al.
Cancer Discov
. 2022 Dec;
13(2):348-363.
PMID: 36477267
Significance: In this study, we established an approach enabling the enumeration and sequencing of CTCs to replace standard molecular cytogenetics. CTCs harbored the same pathognomonic MM abnormalities as BM plasma...